How We’re Different
Starting and ending with patients, we are using our rapid, genome-wide target ID platform to uncover new shared targets in cancer and develop safe and effective T-cell therapies
T-cell therapy unlocks the power of the immune system by re-programming T cells to detect and eliminate cancer cells. The potential of this approach remains largely untapped, however, due to the lack of identified targets.
We are addressing this challenge using our proprietary genome-wide, high-throughput platform to identify the natural targets of anti-tumor T cells residing in the tumors of cancer patients. When we identify a novel target, we simultaneously identify a T cell receptor (TCR) that recognizes that target and can potentially be used in safe and effective TCR T-cell therapy.